Checkpoint Trends Ltd Stock Price Today (NSE: CHECKPOINT)
Fundamental Score
Checkpoint Trends Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Checkpoint Trends Ltd share price today is ₹33.46, up +0.00% on NSE/BSE as of 22 September 2026. Checkpoint Trends Ltd (CHECKPOINT) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹19.83 (Cr). The 52-week high for CHECKPOINT share price is ₹144.40 and the 52-week low is ₹32.00. At a P/E ratio of 13.13x, CHECKPOINT is currently trading below its industry average P/E of 34.89x. The company has a Return on Equity (ROE) of 12.69% and a debt-to-equity ratio of 0.29.
Checkpoint Trends Ltd Share Price Chart — NSE/BSE Historical Performance
Checkpoint Trends Ltd share price chart: -8.18% return over the past month. 52-week high ₹144.40, 52-week low ₹32.00.
Checkpoint Trends Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹32.00 | ₹35.97 | ₹32.00 | ₹33.46 | 1.64K (Cr) | |
| ₹35.00 | ₹35.87 | ₹33.10 | ₹33.45 | 2.34K (Cr) | |
| ₹37.18 | ₹38.95 | ₹35.60 | ₹36.26 | 11.14K (Cr) | |
| ₹39.55 | ₹39.55 | ₹39.55 | ₹39.55 | 0.00 (Cr) | |
| ₹37.01 | ₹39.56 | ₹37.01 | ₹39.55 | 1.38K (Cr) | |
| ₹40.20 | ₹40.20 | ₹37.00 | ₹39.56 | 1.43K (Cr) | |
| ₹42.00 | ₹42.00 | ₹36.58 | ₹36.72 | 716.00 (Cr) | |
| ₹38.98 | ₹42.00 | ₹37.51 | ₹38.20 | 75.00 (Cr) | |
| ₹38.00 | ₹40.00 | ₹37.01 | ₹39.46 | 1.03K (Cr) | |
| ₹37.51 | ₹41.00 | ₹36.13 | ₹37.95 | 2.06K (Cr) |
Checkpoint Trends Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹39.93 | ₹42.50 | ₹32.00 | ₹33.46 | -16.20% | |
| ₹44.20 | ₹47.50 | ₹35.41 | ₹38.60 | -12.67% | |
| ₹45.45 | ₹47.90 | ₹38.94 | ₹46.49 | +2.29% | |
| ₹49.33 | ₹65.79 | ₹35.36 | ₹45.40 | -7.97% | |
| ₹62.61 | ₹62.61 | ₹40.79 | ₹46.99 | -24.95% | |
| ₹114.45 | ₹114.45 | ₹65.90 | ₹65.90 | -42.42% | |
| ₹119.95 | ₹144.40 | ₹115.15 | ₹119.10 | -0.71% | |
| ₹101.24 | ₹114.26 | ₹98.71 | ₹114.26 | +12.86% | |
| ₹69.59 | ₹99.26 | ₹68.20 | ₹99.26 | +42.64% | |
| ₹49.82 | ₹68.23 | ₹49.82 | ₹68.23 | +36.95% | |
| ₹43.42 | ₹48.85 | ₹42.56 | ₹48.85 | +12.51% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Checkpoint Trends Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Checkpoint Trends Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of CHECKPOINT across key market metrics for learning purposes.
Positive Indicators
9 factors identified
Excellent ROCE Performance (15.00%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Attractive Valuation (P/E: 13.13 vs Industry: 34.89)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Strong Revenue Growth (111664.00%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Consistent Growth Track Record (310.88% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Excellent EPS Growth (172.77% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (172.77% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Conservative Debt Levels (D/E: 0.29)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Healthy Liquidity Position (Current Ratio: 6.92)
Observation: Strong short-term liquidity to meet obligations.
Analysis: Current ratio >1.5 indicates good working capital management.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
7 factors identified
Margin Pressure Concerns (0.40%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges.
High Price-to-Book Ratio (32.78x)
Observation: Trading at significant premium to book value.
Analysis: High P/B ratios may indicate overvaluation relative to asset base.
Profit Decline Concern (-700.00%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Negative Free Cash Flow (₹-28.32 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Low Promoter Commitment (0.00%)
Observation: Reduced promoter stake may indicate limited confidence.
Analysis: Low promoter holding may raise questions about management commitment.
Limited Institutional Interest (FII+DII: 8.59%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Checkpoint Trends Ltd vs Pharmaceuticals Peers
Peer Comparison - Pharmaceuticals
Compare Checkpoint Trends Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Checkpoint Trends LtdCheckpoint Tren...Selected✓ CHECKPOINT • 531099 | 51/100 | ₹33.46₹33 | ₹19.83₹19.83 | 13.13Average 13.1 Average | 12.69%Average 12.69% Average | 15.00%Good 15.00% Good | 0.29Excellent 0.3 Excellent | 172.77%Excellent 172.77% Excellent | 310.88%Excellent 310.88% Excellent | 0.00% |
Sun Pharmaceutical Industries LimitedSun Pharmaceuti... SUNPHARMA • 524715 | 66.4/100 | ₹1864.90₹1865 | ₹447445.46₹447445.46 | 37.00Average 37.0 Average | 14.74%Average 14.74% Average | 19.31%Good 19.31% Good | 0.05Excellent 0.0 Excellent | 31.64%Excellent 31.64% Excellent | 11.78%Good 11.78% Good | 0.82% |
Divi's Laboratories LimitedDivi's Laborato... DIVISLAB • 532488 | 56.3/100 | ₹9488.00₹9488 | ₹251432.00₹251432.00 | 86.09Average 86.1 Average | 16.19%Good 16.19% Good | 20.38%Excellent 20.38% Excellent | 0.00Excellent 0.0 Excellent | 5.29%Good 5.29% Good | 8.67%Good 8.67% Good | 0.41% |
Torrent Pharmaceuticals LimitedTorrent Pharmac... TORNTPHARM • 500420 | 51.4/100 | ₹4930.00₹4930 | ₹166860.78₹166860.78 | 78.75Average 78.8 Average | 27.07%Excellent 27.07% Excellent | 14.09%Average 14.09% Average | 1.76Average 1.8 Average | 11.56%Good 11.56% Good | 11.80%Good 11.80% Good | 0.76% |
Zydus Lifesciences LimitedZydus Lifescien... ZYDUSLIFE • 532321 | 74.1/100 | ₹1127.40₹1127 | ₹112514.52₹112514.52 | 25.13Average 25.1 Average | 19.74%Good 19.74% Good | 21.77%Excellent 21.77% Excellent | 0.43Excellent 0.4 Excellent | 18.76%Excellent 18.76% Excellent | 12.45%Good 12.45% Good | 0.09% |
Cipla LimitedCipla Limited... CIPLA • 500087 | 40.2/100 | ₹1363.10₹1363 | ₹110118.03₹110118.03 | 32.66Average 32.7 Average | 11.82%Average 11.82% Average | 15.67%Good 15.67% Good | 0.01Excellent 0.0 Excellent | 10.03%Good 10.03% Good | 8.01%Good 8.01% Good | 0.90% |
Laurus Labs LimitedLaurus Labs Lim... LAURUSLABS • 540222 | 34.1/100 | ₹1937.00₹1937 | ₹104646.43₹104646.43 | 95.61Average 95.6 Average | 18.19%Good 18.19% Good | 21.35%Excellent 21.35% Excellent | 0.45Excellent 0.5 Excellent | -1.89%Poor -1.89% Poor | 7.19%Good 7.19% Good | 0.13% |
Aurobindo Pharma LimitedAurobindo Pharm... AUROPHARMA • 524804 | 24.6/100 | ₹1698.90₹1699 | ₹97754.71₹97754.71 | 26.55Average 26.5 Average | 9.94%Poor 9.94% Poor | 14.54%Average 14.54% Average | 0.20Excellent 0.2 Excellent | -8.07%Poor -8.07% Poor | 6.32%Good 6.32% Good | 0.26% |
Lupin LimitedLupin Limited... LUPIN • 500257 | 83.4/100 | ₹2100.00₹2100 | ₹96022.50₹96022.50 | 17.35Average 17.4 Average | 26.90%Excellent 26.90% Excellent | 31.80%Excellent 31.80% Excellent | 0.26Excellent 0.3 Excellent | 34.39%Excellent 34.39% Excellent | 13.02%Good 13.02% Good | 0.72% |
Dr. Reddy's Laboratories LimitedDr. Reddy's Lab... DRREDDY • 500124 | 41/100 | ₹1145.00₹1145 | ₹95607.50₹95607.50 | 29.59Average 29.6 Average | 11.75%Average 11.75% Average | 14.80%Average 14.80% Average | 0.17Excellent 0.2 Excellent | 16.54%Excellent 16.54% Excellent | 12.09%Good 12.09% Good | 0.65% |
Mankind Pharma LimitedMankind Pharma ... MANKIND • 543904 | 61.5/100 | ₹2265.00₹2265 | ₹93544.50₹93544.50 | 45.77Average 45.8 Average | 12.49%Average 12.49% Average | 13.56%Average 13.56% Average | 0.39Excellent 0.4 Excellent | 10.52%Good 10.52% Good | 18.10%Excellent 18.10% Excellent | 0.04% |
Top Pharmaceuticals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Sun Pharmaceutical Industries Limited share price447445.46 Cr
- Divi's Laboratories Limited share price251432.00 Cr
- Torrent Pharmaceuticals Limited share price166860.78 Cr
- Zydus Lifesciences Limited share price112514.52 Cr
- Cipla Limited share price110118.03 Cr
Checkpoint Trends Ltd PE Ratio History
Historical price-to-earnings ratio for CHECKPOINT — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2025 | ₹0.05 | ₹114.26 | 2285.2x |
| FY 2024 | ₹0.06 | ₹13.05 | 217.5x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Checkpoint Trends Ltd Quarterly Performance
Latest quarterly metrics for CHECKPOINT — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
111664.00%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-700.00%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
310.88%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
172.77%
Compounded annual net profit growth over 5 years
Checkpoint Trends Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for CHECKPOINT — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Checkpoint Trends Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Checkpoint Trends Ltd (CHECKPOINT) — sourced from NSE/BSE filings.
Financial Results & Statements
Latest quarterly, annual and period-wise financial data for Checkpoint Trends Ltd
About CHECKPOINT (Checkpoint Trends Ltd)
Checkpoint Trends Ltd is a dynamic pharmaceutical enterprise carving a unique niche within the Indian healthcare landscape. While rooted in a foundational trading business, the com...pany's strategic vision extends beyond mere distribution. Checkpoint Trends is actively cultivating a portfolio of specialized pharmaceutical products, focusing on therapeutic areas with unmet needs and significant growth potential. Their approach involves identifying and sourcing innovative formulations, leveraging established distribution networks, and forging strategic alliances to bring cutting-edge treatments to market. Through meticulous market analysis and a commitment to quality, Checkpoint Trends is poised to become a trusted provider of specialized pharmaceuticals, offering valuable solutions to both healthcare professionals and patients. Central to Checkpoint Trends' operational philosophy is a commitment to providing comprehensive value beyond simply offering products. Recognizing the complexities of the pharmaceutical sector, the company offers a suite of management and consultancy services, drawing on its deep understanding of the Indian healthcare market. These services are designed to empower partner companies and healthcare providers, enabling them to navigate regulatory hurdles, optimize supply chains, and implement best practices in patient care. By combining its trading expertise with its advisory capabilities, Checkpoint Trends aims to foster a collaborative ecosystem within the pharmaceutical industry, contributing to the overall advancement of healthcare delivery and the improvement of patient outcomes. Originally established in 1991 as Rubra Medicaments Limited and rebranding to Checkpoint Trends Limited in May 2022, the company's evolution reflects its adaptability and forward-thinking approach. Headquartered in Mumbai, India, Checkpoint Trends benefits from its strategic location within one of the country's major pharmaceutical hubs. The company's enduring presence in the market provides a solid foundation for future expansion and innovation. By remaining agile and responsive to emerging trends, Checkpoint Trends is well-positioned to capitalize on the evolving demands of the Indian pharmaceutical market and solidify its position as a key player in the industry.
Company Details
Key Leadership
CHECKPOINT Share Price: Frequently Asked Questions
What is the current share price of Checkpoint Trends Ltd?
Checkpoint Trends Ltd (CHECKPOINT) trades at ₹33.46 on NSE and BSE. Market cap ₹19.83 (Cr). Educational data only.
What is the P/E ratio of Checkpoint Trends Ltd?
Checkpoint Trends Ltd has a P/E of 13.13x vs industry average 34.89x.
What is the Bull Run score for Checkpoint Trends Ltd?
Checkpoint Trends Ltd has a Bull Run score of 51/100 based on 25+ financial parameters.
Does Checkpoint Trends Ltd pay dividends?
Checkpoint Trends Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Checkpoint Trends Ltd?
Checkpoint Trends Ltd has ROE of 12.69%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Checkpoint Trends Ltd?
Checkpoint Trends Ltd has debt-to-equity of 0.29.
Is Checkpoint Trends Ltd a good investment?
Bull Run gives Checkpoint Trends Ltd a score of 51/100. This is not investment advice — consult a SEBI-registered advisor.